Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- HC Wainwright & Co.
- SVB Leerink
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for AC Immune
What is the target price for AC Immune (ACIU)?
The latest price target for AC Immune (NASDAQ: ACIU) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $16.00 expecting ACIU to rise to within 12 months (a possible 428.05% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AC Immune (ACIU)?
The latest analyst rating for AC Immune (NASDAQ: ACIU) was provided by HC Wainwright & Co., and AC Immune reiterated their buy rating.
When is the next analyst rating going to be posted or updated for AC Immune (ACIU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AC Immune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AC Immune was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
Is the Analyst Rating AC Immune (ACIU) correct?
While ratings are subjective and will change, the latest AC Immune (ACIU) rating was a reiterated with a price target of $0.00 to $16.00. The current price AC Immune (ACIU) is trading at is $3.03, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.